Aptose Biosciences (APTO) Short Interest Ratio & Short Volume → They said crypto was dead. It went up 100X. (From InvestorPlace) (Ad) Free APTO Stock Alerts $1.50 -0.02 (-1.32%) (As of 03/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Aptose Biosciences Short Interest DataCurrent Short Volume70,400 sharesPrevious Short Volume90,600 sharesChange Vs. Previous Month-22.30%Dollar Volume Sold Short$126,720.00Short Interest Ratio / Days to Cover0.8Last Record DateFebruary 29, 2024Outstanding Shares15,710,000 sharesFloat Size9,330,000 sharesShort Percent of Float0.75%Today's Trading Volume40,035 sharesAverage Trading Volume93,946 sharesToday's Volume Vs. Average43% Short Selling Aptose Biosciences ? Sign up to receive the latest short interest report for Aptose Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAPTO Short Interest Over TimeAPTO Days to Cover Over TimeAPTO Percentage of Float Shorted Over Time Ad Banyan Hill PublishingAI Cracks Open Largest Untapped Energy Reserve on EarthThis orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… ]click here to watch a free presentation where I reveal all the details of this lucrative opportunit Aptose Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/202470,400 shares $126,720.00 -22.3%0.8%0.8 $1.80 2/15/202490,600 shares $183,265.68 -53.0%1.0%1 $2.02 1/31/2024192,600 shares $385,200.00 +31.9%6.2%2.5 $2.00 1/15/2024146,000 shares $332,880.00 +66.5%4.0%2.6 $2.28 12/31/202387,700 shares $222,758.00 +32.3%2.4%1.6 $2.54 12/15/202366,300 shares $157,131.00 +193.4%1.8%1.3 $2.37 Get the Latest News and Ratings for APTO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aptose Biosciences and its competitors with MarketBeat's FREE daily newsletter. 11/30/202322,600 shares $54,918.00 -25.9%0.7%0.5 $2.43 11/15/202330,500 shares $82,655.00 -27.2%1.0%0.8 $2.71 10/31/202341,900 shares $116,901.00 +37.8%1.7%1 $2.79 10/15/202330,400 shares $65,056.00 -24.4%1.2%0.7 $2.14 9/30/202340,200 shares $112,560.00 +37.7%1.8%1 $2.80 9/15/202329,200 shares $96,068.00 -22.8%1.3%0.7 $3.29 8/31/202337,800 shares $153,090.00 -7.1%1.8%0.8 $4.05 8/15/202340,700 shares $199,430.00 -12.9%1.3%0.9 $4.90 7/31/202346,700 shares $144,770.00 -28.4%2.2%1.1 $3.10 7/15/202365,200 shares $288,836.00 -18.2%3.1%1.8 $4.43 6/30/202379,700 shares $369,808.00 -3.4%1.4%2.5 $4.64 6/15/202382,500 shares $485,925.00 +167.0%1.4%2.9 $5.89 5/31/202330,900 shares $190,035.00 -88.3%N/A1.6 $6.15 5/15/2023264,100 shares $124,655.20 +44.6%0.3%1.5 $0.47 4/30/2023182,700 shares $88,189.29 +11.3%0.2%1.1 $0.48 4/15/2023164,100 shares $84,027.41 -37.4%0.2%0.9 $0.51 3/31/2023262,200 shares $167,808.00 +53.3%0.3%1.4 $0.64 3/15/2023171,000 shares $99,180.00 -3.0%0.2%0.8 $0.58 2/28/2023176,200 shares $102,548.40 +0.7%0.2%0.6 $0.58 2/15/2023175,000 shares $119,000.00 -13.9%0.2%0.6 $0.68 1/31/2023203,300 shares $152,475.00 -74.0%0.2%0.7 $0.75 1/15/2023782,400 shares $547,680.00 -19.6%0.9%1.8 $0.70 12/30/2022973,500 shares $564,630.00 -3.6%N/A2.3 $0.58 12/15/20221,010,000 shares $591,153.00 +29.1%N/A2.5 $0.59 11/30/2022782,300 shares $520,229.50 +13.0%N/A2.2 $0.67 11/15/2022692,100 shares $472,289.04 +163.7%N/A1.9 $0.68 10/31/2022262,500 shares $120,881.25 -4.0%N/A0.7 $0.46 10/15/2022273,300 shares $155,808.33 +14.6%N/A1.3 $0.57 9/30/2022238,400 shares $141,848.00 -2.9%N/A1.3 $0.60 9/15/2022245,600 shares $170,937.60 +18.7%N/A1.3 $0.70 8/31/2022206,900 shares $161,795.80 -15.9%N/A1 $0.78 8/15/2022245,900 shares $213,933.00 -16.7%N/A1.1 $0.87 7/31/2022295,100 shares $218,993.71 +10.5%N/A1.1 $0.74 7/15/2022267,100 shares $223,055.21 +4.8%N/A0.9 $0.84Did you make $29,000 two days with AI options trades? (Ad)What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:Click Here To Get Your Free Copy APTO Short Interest - Frequently Asked Questions What is Aptose Biosciences' current short interest? Short interest is the volume of Aptose Biosciences shares that have been sold short but have not yet been covered or closed out. As of February 29th, traders have sold 70,400 shares of APTO short. 0.75% of Aptose Biosciences' shares are currently sold short. Learn More on Aptose Biosciences' current short interest. What is a good short interest ratio for Aptose Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. APTO shares currently have a short interest ratio of 1.0. Learn More on Aptose Biosciences's short interest ratio. Which institutional investors are shorting Aptose Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aptose Biosciences: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Aptose Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.75% of Aptose Biosciences' floating shares are currently sold short. Is Aptose Biosciences' short interest increasing or decreasing? Aptose Biosciences saw a drop in short interest in February. As of February 29th, there was short interest totaling 70,400 shares, a drop of 22.3% from the previous total of 90,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aptose Biosciences' float size? Aptose Biosciences currently has issued a total of 15,710,000 shares. Some of Aptose Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aptose Biosciences currently has a public float of 9,330,000 shares. How does Aptose Biosciences' short interest compare to its competitors? 0.75% of Aptose Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Aptose Biosciences: ZIVO Bioscience, Inc. (4.24%), Surrozen, Inc. (0.19%), PharmaCyte Biotech, Inc. (0.33%), Senti Biosciences, Inc. (1.03%), SAB Biotherapeutics, Inc. (0.33%), Acorda Therapeutics, Inc. (0.90%), MiNK Therapeutics, Inc. (0.42%), Brainstorm Cell Therapeutics Inc. (2.18%), Coeptis Therapeutics Holdings, Inc. (0.76%), TRACON Pharmaceuticals, Inc. (0.99%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short Aptose Biosciences stock? Short selling APTO is an investing strategy that aims to generate trading profit from Aptose Biosciences as its price is falling. APTO shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aptose Biosciences? A short squeeze for Aptose Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APTO, which in turn drives the price of the stock up even further. How often is Aptose Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APTO, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: ZIVO Bioscience Short Interest Data Surrozen Short Interest Data PharmaCyte Biotech Short Interest Data Senti Biosciences Short Interest Data SAB Biotherapeutics Short Interest Data Acorda Therapeutics Short Interest Data MiNK Therapeutics Short Interest Data Brainstorm Cell Therapeutics Short Interest Data Coeptis Therapeutics Short Interest Data TRACON Pharmaceuticals Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:APTO) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingBill Gates Bets on $15 Trillion BonanzaWeiss RatingsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company